Usana Health Sciences Inc SEC filings USNA
Usana Health Sciences Inc has 1,001 filings in SEC EDGAR's recent list, going back to Nov 13, 2017. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Jan 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jul 4, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 5, 2026 | Oct 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jul 4, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 25, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 25, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 144 | Notice of proposed sale | Jun 16, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 11-K | Employee savings plan report | Jun 15, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 8, 2026 |
| 144 | Notice of proposed sale | Jun 8, 2026 | — |
| 4 | Insider transaction | Jun 1, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 144 | Notice of proposed sale | May 28, 2026 | — |
| 4 | Insider transaction | May 28, 2026 | May 27, 2026 |
| 144 | Notice of proposed sale | May 27, 2026 | — |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Apr 4, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 7, 2026 |
| 144 | Notice of proposed sale | May 7, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2026 | May 5, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| ARS | Annual report to shareholders | Apr 7, 2026 | Jan 3, 2026 |
| DEF 14A | Proxy statement | Apr 7, 2026 | Jan 3, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 30, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4 | Insider transaction | Mar 20, 2026 | Mar 20, 2026 |
| 10-K | Annual report | Mar 16, 2026 | Jan 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 144 | Notice of proposed sale | Feb 20, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 18, 2026 | Feb 17, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 11, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 10, 2025 |
| 144 | Notice of proposed sale | Dec 10, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 27, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 22, 2025 | Oct 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 9, 2025 | Oct 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 9, 2025 | — |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 4 | Insider transaction | Aug 8, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 28, 2025 |
| 4 | Insider transaction | Jul 31, 2025 | Jul 30, 2025 |
| 144 | Notice of proposed sale | Jul 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| 4 | Insider transaction | Jul 28, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 22, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 1, 2025 | Jun 27, 2025 |
| 11-K | Employee savings plan report | Jun 20, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| S-8 | Employee stock plan registration | May 21, 2025 | — |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
May 20, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 9, 2025 |
| 144 | Notice of proposed sale | May 9, 2025 | — |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 29, 2025 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 22, 2025 | Apr 22, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 28, 2024 |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | Dec 28, 2024 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 12, 2025 |
| 144 | Notice of proposed sale | Mar 12, 2025 | — |
| 144 | Notice of proposed sale | Mar 12, 2025 | — |
| 10-K | Annual report | Mar 12, 2025 | Dec 28, 2024 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 10, 2025 |
| 144 | Notice of proposed sale | Mar 10, 2025 | — |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 144 | Notice of proposed sale | Mar 7, 2025 | — |
| 8-K/A | Amended current report | Mar 7, 2025 | Dec 23, 2024 |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 4 | Insider transaction | Mar 3, 2025 | Mar 3, 2025 |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 8, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- USNA (NYSE)
- Fiscal year ends
- January 3
- Incorporated in
- UT
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 896264
- Former names
- USANA INC (until Apr 27, 2000)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.